FDA Reviewers Mixed Over Two New Cancer Drugs
19968
U.S. Food and Drug Administration  staff reviewers on Tuesday questioned clinical data for  non-Hodgkin's lymphoma drug Marqibo, made by Inex  Pharmaceuticals Corp. and Enzon Pharmaceuticals Inc..
467984
The US Food and Drug Administration approved a new drug to treat patients with advanced lung cancer. It&#39;s called Alimta. Patients receive ten minute infusions of the drug every three weeks on an outpatient basis.
404075
New evidence is raising questions about the tests used to prescribe the breast cancer drug Herceptin, which was initially seen as a model for tailored medicine.
458921
Congress is looking into whether the Food and Drug Administration ignored safety concerns about the drug raised by its own reviewers and outside scientists.
304755
TORONTO - A standard treatment used to prevent the recurrence of breast cancer should be replaced by a newer drug, according to a study released Wednesday.
502607
Doctors are hopeful about a new drug to treat skin cancer by causing tumor cells to self-destruct by overloading them with oxygen
84184
As the Food and Drug Administration prepares to make recommendations about Pfizer&#39;s (PFE:NYSE - news - research) Celebrex, the companies that ultimately pay for the drug aren&#39;t leaping to conclusions merely because one recent study showed patients taking
421686
Five years ago, Portland&#39;s Dr. Brian Druker told a gathering of blood scientists about a few dozen cancer patients who were taking an obscure new drug with surprising success.
563877
A new type of breast cancer drug is  clearly superior to the old standard, tamoxifen, in many women  and should now be the first drug used to treat the cancer, U.S.  and British researchers said on Wednesday.
26465
The Bush administration and some of its critics squared off yesterday over whether the Food and Drug Administration is doing an adequate
586343
U.S. regulators said on Thursday they were reviewing two recent studies that provided more evidence of serious risks for some cancer patients treated with anemia drugs sold by Amgen Inc  and Johnson & Johnson .
691976
Washington, Dec 16 : One-fifth of the US Food and Drug Administration (FDA) scientists surveyed as part of an official review have said they had been pressured to recommend approval of a new drug despite their reservations about its safety, effectiveness
565009
Some of the health benefits claimed for a new weight loss drug may not be justified, say experts.
101669
A new analysis finds that clinical trials of breast-cancer treatments by drugmakers show positive results far more often than non-industry trials. Why the difference?
243349
This lung cancer drug is not as effective as once hoped.
765930
U.S. regulators said on Friday they  would review a study showing a Merck and Schering-Plough  cholesterol drug worked no better than a generic in preventing  the build-up of arterial plaque.
152135
Debate about the safety of a group of anemia drugs widely used in cancer patients should focus on a minority of patients who got the drugs for unapproved uses, doctors said on Sunday.